ReviewInfection and drug resistance2016

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Travis M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.